Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia.
Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Mori C, von Eisenhart Rothe B, Pocock S, Poole-Wilson PA, Ponikowski P; FAIR-HF committees and investigators. Anker SD, et al. Among authors: willenheimer r. Eur J Heart Fail. 2009 Nov;11(11):1084-91. doi: 10.1093/eurjhf/hfp140. Eur J Heart Fail. 2009. PMID: 19875408 Free PMC article. Clinical Trial.
Ferric carboxymaltose in patients with heart failure and iron deficiency.
Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P; FAIR-HF Trial Investigators. Anker SD, et al. Among authors: willenheimer r. N Engl J Med. 2009 Dec 17;361(25):2436-48. doi: 10.1056/NEJMoa0908355. Epub 2009 Nov 17. N Engl J Med. 2009. PMID: 19920054 Free article. Clinical Trial.
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study.
Comin-Colet J, Lainscak M, Dickstein K, Filippatos GS, Johnson P, Lüscher TF, Mori C, Willenheimer R, Ponikowski P, Anker SD. Comin-Colet J, et al. Among authors: willenheimer r. Eur Heart J. 2013 Jan;34(1):30-8. doi: 10.1093/eurheartj/ehr504. Epub 2012 Jan 31. Eur Heart J. 2013. PMID: 22297124 Free PMC article. Clinical Trial.
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial.
Filippatos G, Farmakis D, Colet JC, Dickstein K, Lüscher TF, Willenheimer R, Parissis J, Gaudesius G, Mori C, von Eisenhart Rothe B, Greenlaw N, Ford I, Ponikowski P, Anker SD. Filippatos G, et al. Among authors: willenheimer r. Eur J Heart Fail. 2013 Nov;15(11):1267-76. doi: 10.1093/eurjhf/hft099. Epub 2013 Jun 19. Eur J Heart Fail. 2013. PMID: 23787722 Free PMC article. Clinical Trial.
The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study.
Ponikowski P, Filippatos G, Colet JC, Willenheimer R, Dickstein K, Lüscher T, Gaudesius G, von Eisenhart Rothe B, Mori C, Greenlaw N, Ford I, Macdougall I, Anker SD; FAIR-HF Trial Investigators. Ponikowski P, et al. Among authors: willenheimer r. Eur J Heart Fail. 2015 Mar;17(3):329-39. doi: 10.1002/ejhf.229. Epub 2015 Feb 11. Eur J Heart Fail. 2015. PMID: 25683972 Free PMC article. Clinical Trial.
Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.
Krum H, van Veldhuisen DJ, Funck-Brentano C, Vanoli E, Silke B, Erdmann E, Follath F, Ponikowski P, Goulder M, Meyer W, Lechat P, Willenheimer R; behalf of the CIBIS III Investigators. Krum H, et al. Among authors: willenheimer r. Cardiovasc Ther. 2011 Apr;29(2):89-98. doi: 10.1111/j.1755-5922.2010.00185.x. Cardiovasc Ther. 2011. PMID: 20528880 Free article. Clinical Trial.
124 results